Escin’s Action on Bradykinin Pathway: Advantageous Clinical Properties for an Unknown Mechanism?
Escin, extracted from horse chestnut (<i>Aesculus hippocastanum</i>) has anti-edema and anti-inflammatory effects. It is used to treat several clinical conditions, including venous insufficiency, pain, inflammation, and edema. Considering escin’s pharmacodynamic, the inhibition of the br...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-09-01
|
| Series: | Antioxidants |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3921/13/9/1130 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Escin, extracted from horse chestnut (<i>Aesculus hippocastanum</i>) has anti-edema and anti-inflammatory effects. It is used to treat several clinical conditions, including venous insufficiency, pain, inflammation, and edema. Considering escin’s pharmacodynamic, the inhibition of the bradykinin pathway represents a particular effect, decreasing the local edema and conferring an advantage in comparison to other compounds. In this narrative review, we described the effects of escin considering its effects on bradykinin pathway. |
|---|---|
| ISSN: | 2076-3921 |